These findings underscore that Mertk plays a key pathogenic role in the development of AD, as it functions as a phagocytic receptor in both physiological and pathological pruning 42, 44, and also provide a basis for considering Mertk as a potential therapeutic target in AD management. This evidence concerns the gene MERTK and Alzheimer disease.